Study on Delayed Graft Function Using Paired Kidneys

PHASE2UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 29, 2016

Study Completion Date

May 31, 2016

Conditions
Delayed Graft Function
Interventions
DRUG

BB3

Daily intravenous administration of 2mg/kg for 4 days

DRUG

Normal Saline

Daily intravenous administration for four (4) days. The volume of normal saline will vary by estimated weight.

Trial Locations (3)

28001

Hospital Clínico San Carlos, San Carlos

6211 LK

Maastricht University Medical Center, Minderbroedersberg

NE7 7DN

The Newcastle Upon Tyne Hospital, Newcastle

Sponsors
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Angion Biomedica Corp

INDUSTRY

NCT01561599 - Study on Delayed Graft Function Using Paired Kidneys | Biotech Hunter | Biotech Hunter